CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY
- PMID: 31577079
- DOI: 10.15586/jptcp.v26i2.599
CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY
Abstract
Obesity is a growing health problem worldwide, and it is associated with serious medical and psychosocial comorbidities, impairment of health-related quality of life (HRQoL) and an increased risk of mortality. This article aims to discuss challenges faced by health-care providers when managing patients with obesity and to highlight sustainable policies in clinical practice and future research. All health professionals dealing with obesity should consider lifestyle-modification programmes within a multidisciplinary setting as the key element of weight management. However, standardisation is needed in terms of nature, content and duration of these programmes in order to facilitate their implementation in clinical practice at different levels. Moreover, health professionals should be aware that these programmes, for patients indicating "non-response," can be combined with recently approved anti-obesity drugs such as liraglutide, naltrexone/bupropion, lorcaserin and phentermine/topiramate, as well as with relatively less invasive bariatric surgery techniques such as Lap Band, endoscopic sleeve gastroplasty and gastric bypass. In any case, neither anti-obesity medication nor bariatric surgery should be considered as a miracle treatment in itself. At the same time, the field of obesity is still lacking in literature on some hot topics that need further investigation, including (i) a new phenotype termed sarcopenic obesity, to clarify its definition, potential health consequences and eventual treatment if necessary; (ii) issues that go beyond body weight, for instance, HRQoL that has been poorly studied in some populations affected by obesity; and (iii) the long-term effect of sleeve gastrectomy technique, which is becoming the most commonly used bariatric surgical procedure, perhaps to be studied using long-term randomised controlled trials that guarantee completeness of follow-up, in order to avoid misunderstanding and bias in interpretation of results.
Keywords: Bariatric surgery; Lifestyle modification; Obesity; Sarcopenic obesity; Weight loss; Weight regain.
© 2019 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.
Conflict of interest statement
The authors have no conflict of interest to declare.
Similar articles
-
Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database.Obes Surg. 2024 May;34(5):1415-1424. doi: 10.1007/s11695-024-07181-w. Epub 2024 Mar 21. Obes Surg. 2024. PMID: 38512645
-
Weight Loss Pharmacotherapy: Current and Future Therapies.Gastrointest Endosc Clin N Am. 2024 Oct;34(4):591-608. doi: 10.1016/j.giec.2024.06.006. Gastrointest Endosc Clin N Am. 2024. PMID: 39277293 Review.
-
Efficacy of adjuvant weight loss medication after bariatric surgery.Surg Obes Relat Dis. 2018 Jan;14(1):93-98. doi: 10.1016/j.soard.2017.10.002. Epub 2017 Oct 9. Surg Obes Relat Dis. 2018. PMID: 29287757
-
Management of obesity.Lancet. 2016 May 7;387(10031):1947-56. doi: 10.1016/S0140-6736(16)00271-3. Epub 2016 Feb 10. Lancet. 2016. PMID: 26868660 Review.
-
Weight loss strategies for treatment of obesity.Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):465-72. doi: 10.1016/j.pcad.2013.09.005. Epub 2013 Oct 11. Prog Cardiovasc Dis. 2014. PMID: 24438739 Review.
Cited by
-
Do Lifestyle Interventions before Gastric Bypass Prevent Weight Regain after Surgery? A Five-Year Longitudinal Study.Nutrients. 2022 Aug 31;14(17):3609. doi: 10.3390/nu14173609. Nutrients. 2022. PMID: 36079866 Free PMC article.
-
The Role of Obesity, Body Composition, and Nutrition in COVID-19 Pandemia: A Narrative Review.Nutrients. 2022 Aug 25;14(17):3493. doi: 10.3390/nu14173493. Nutrients. 2022. PMID: 36079751 Free PMC article. Review.
-
Association Between Reduced Daily Steps and Sarcopenic Obesity in Treatment-Seeking Adults With Obesity.Front Endocrinol (Lausanne). 2020 Jan 30;11:22. doi: 10.3389/fendo.2020.00022. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32082259 Free PMC article.
-
Sarcopenic Obesity Predicts Early Attrition in Treatment-Seeking Patients with Obesity: A Longitudinal Pilot Study.J Cardiovasc Dev Dis. 2020 Jan 27;7(1):5. doi: 10.3390/jcdd7010005. J Cardiovasc Dev Dis. 2020. PMID: 32012690 Free PMC article.
-
New BMI Cut-Off Points for Obesity in Middle-Aged and Older Adults in Clinical Nutrition Settings in Italy: A Cross-Sectional Study.Nutrients. 2022 Nov 16;14(22):4848. doi: 10.3390/nu14224848. Nutrients. 2022. PMID: 36432532 Free PMC article.
References
-
- 1. Collaborators GBDO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27. - DOI
-
- 2. Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12:40–66. - DOI
-
- 3. El Ghoch M, Calugi S, Dalle Grave R. Weight cycling in adults with severe obesity: A longitudinal study. Nutr Diet. 2018;75:256–62. - DOI
-
- 4. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132:2226–38. - DOI
-
- 5. Dalle Grave R, Calugi S, El Ghoch M. Lifestyle modification in the management of obesity: Achievements and challenges. Eat Weight Disord. 2013;18:339–49. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials